Related Experiment Video
Updated: May 20, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications
Chang-Ching Wei1, Wei Wang, William E Smoyer
1Department of Pediatrics, Division of Nephrology, China Medical University Hospital, Taichung, Taiwan.
Insights
Pediatric membranoproliferative glomerulonephritis (MPGN) hospitalizations remained stable, but acute renal failure, length of stay, and costs significantly increased over a decade. Understanding these trends is vital for future pediatric kidney disease care.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Healthcare Economics
Background:
- Pediatric membranoproliferative glomerulonephritis (MPGN) data is crucial for understanding its economic impact and guiding future research.
- Epidemiology, complications, and healthcare costs of pediatric MPGN require thorough investigation.
Purpose of the Study:
- To analyze 10-year trends in pediatric primary MPGN hospitalizations.
- To assess changes in epidemiology, complications, and hospital charges associated with pediatric MPGN.
Main Methods:
- Utilized the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID) from 1997-2006.
- Analyzed approximately 320 annual pediatric primary MPGN admissions, representing 4.3% of glomerular disease admissions.
Main Results:
- Older children (6-18 years) faced higher MPGN admission risks.
- MPGN-associated acute renal failure (ARF) incidence rose over 147%, while renal biopsy, replacement therapy, and transplantation rates remained constant.
- Hospital length of stay increased by 68%, and mean hospital charges surged by 213%.
Conclusions:
- Pediatric primary MPGN hospitalizations remained stable in incidence over 10 years.
- Associated ARF frequency, hospital length of stay, and charges saw dramatic increases.
- These findings highlight evolving challenges in managing pediatric MPGN.
Background:
Data on pediatric membranoproliferative glomerulonephritis (MPGN) epidemiology, complications, and healthcare costs are critical to our understanding of MPGN's economic burden and of how best to direct clinical care and research efforts in the future.
Methods:
We analyzed 10-year trends in epidemiology, complications, and hospital charges for pediatric primary MPGN hospitalizations using the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID) for 1997-2006. We identified approximately 320 primary MPGN admissions per year, corresponding to approximately 4.3 % of all glomerular disease admissions.
Results:
Older children were at higher risk for admission (odds ratios for ages 6-10, 11-15, and 16-18 years were 7.5, 9.3, and 4.7, respectively compared to 0-5 years; p < 0.0001). Gender, race, income, hospital location, and admission season were not significant risk factors. The incidence of MPGN admission-associated acute renal failure (ARF) increased to >147 % (from <3 to 7.4 %) over time, while admission-associated renal biopsy (approx. 34.8 %), renal replacement therapy (approx. 18.4 %), and transplantation (approx. 5 %) remained constant. Hospital length of stay (LOS) increased by 68 % (from 5.0 to 8.4 days), whereas mean total hospital charges increased by 213 % (from $13,718 to $42,891), concomitant with a strong trend from private toward public health insurance.
Conclusions:
We conclude that while the incidence of pediatric primary MPGN hospitalizations has remained stable over the last 10 years, they have been associated with marked increases in the frequency of ARF, as well as dramatically increased hospital LOS and charges.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management

